登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CCR4】

CCR4信息

英文名称:C-C chemokine receptor type 4
中文名称:C-C趋化因子受体4型
靶点别称:Chemokine (C-C Motif) Receptor 4,CD194 Antigen,K5-5,CD194,CCR-4,C-C chemokine receptor type 4,CCR4,C-C Motif Chemokine Receptor 4,C-C CKR-4,CC-CKR-4,CMKBR4,Chemokine (C-C) Receptor 4,HGCN:14099,ChemR13,CKR4,Receptors, CCR4
上市药物数量:1
临床药物数量:1
最高研发阶段:批准上市

CCR4产品列表

ACRO质量管理体系
 
评论(0)
 

CCR4分子别名

CKR4, K5-5,CD194,CMKBR4,ChemR13,CC-CKR-4,HGCN:14099

CCR4分子背景

C-C chemokine receptor type 4 is a receptor for the following CC chemokines: CCL2, CCL4, CCL5, CCL17, CCL22, belongs to the G protein-coupled receptor family. Chemokines are a group of small polypeptide, structurally related molecules that regulate cell trafficking of various types of leukocytes. The chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. CCR4 is often expressed on leukemic cells in cutaneous T-cell lymphoma (CTCL). Mogamulizumab is a humanized monoclonal antibody targeted at CCR4and is an investigational drug for CTCL.

CCR4上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

CCR4临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定